Advertisement
July 16 2020 4:05pm

Baby Kaysen update on push to raise $2.8M for life-saving gene therapy

Kaysen Martin needs a life-saving gene therapy for spinal muscular atrophy Type 1 (SMA 1). Zolgensma costs $2.8 million and has to be administered before his second birthday — which is tomorrow. Nicole Stillger has this update on the push to pay for the drug.

Responsive site?

Video Home